| 000 | 01668 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516150925.0 | ||
| 264 | 0 | _c20131024 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1525-2191 | ||
| 024 | 7 |
_a10.1016/j.ajpath.2013.04.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGilbert, Emily R | |
| 245 | 0 | 0 |
_aPositioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis. _h[electronic resource] |
| 260 |
_bThe American journal of pathology _cJul 2013 |
||
| 300 |
_a226-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, CD1d _xmetabolism |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _ximmunology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aGangliosides _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _ximmunology |
| 650 | 0 | 4 |
_aLung Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aLymphangioleiomyomatosis _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNatural Killer T-Cells _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aEby, Jonathan M | |
| 700 | 1 | _aHammer, Adam M | |
| 700 | 1 | _aKlarquist, Jared | |
| 700 | 1 | _aChristensen, David G | |
| 700 | 1 | _aBarfuss, Allison J | |
| 700 | 1 | _aBoissy, Raymond E | |
| 700 | 1 | _aPicken, Maria M | |
| 700 | 1 | _aLove, Robert B | |
| 700 | 1 | _aDilling, Daniel F | |
| 700 | 1 | _aLe Poole, I Caroline | |
| 773 | 0 |
_tThe American journal of pathology _gvol. 183 _gno. 1 _gp. 226-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajpath.2013.04.002 _zAvailable from publisher's website |
| 999 |
_c22742796 _d22742796 |
||